OVO is developing sex reversal technology for the broiler industry. In broiler breeds, males are considered 15-20% more economically efficient than females. A broiler grower can profit $0.5 more for every male he grows. Our solution is a natural material composition injected directly to chicken embryos, and result in the development of female broilers that function like males in terms of weight gain and feed-conversion-ratio. The materials we use are safe for human consumption in large dosages.
Part of BioMeat R&D Partnership (TASE:BIMT.L)
Part of BioMeat R&D Partnership (TASE:BIMT.L)
Location: Israel, Center District, Kidron
Employees: 1-10
Founded date: 2018